Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> Africa’s Methane Gamble – Can A Climate-Warming Gas Become An Asset to Health? 07/11/2021 Paul Adepoju & Elaine Ruth Fletcher GLASGOW – Nearly two dozen African countries, including some of the continent’s biggest methane- producing nations, have now signed The Global Methane Pledge, launched Tuesday at COP26 by United States President Joe Biden and the President of the European Commission, Ursula von der Leyen. While the pledge was initially announced in September with nine countries […] Continue reading -> Children’s Health Hit Hardest by Climate Change – but Cleaner Air, Greener Cities and Healthier Foods Can Create Cascade of Benefits 07/11/2021 Elaine Ruth Fletcher Greening cities, investing in urban bike lanes rather than new roads, and making plant-based foods cheaper and easier to access than ultra-processed foods. This is a doctor’s prescription for a healthier planet. As climate negotiators at Glasgow’s COP26 conference remain locked in debate over the big-picture ambition of targets for global CO2 emissions reductions, and […] Continue reading -> The African Medicines Agency Countdown 05/11/2021 Editorial team Thirty-nine of the African Union’s 55 member states have now signed and/or ratified the African Medicines Agency Treaty, as of 6 July 2024, with Kenya, the Democratic Republic of Congo and Cape Verde amongst the latest to swing behind the treaty. As the countdown for other nations to sign continues, Health Policy Watch is tracking […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Global COVID-19 Deaths: 5 Million and Counting 02/11/2021 Raisa Santos More than 5 million people have officially died from COVID-19 less than two years into the global pandemic. COVID-19 is now the third leading cause of death, after heart disease and stroke. There have been 5,003,021 COVID-19 related deaths as of 1 November, according to the Johns Hopkins COVID-19 Dashboard. In the United States, 746,021 […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa’s Methane Gamble – Can A Climate-Warming Gas Become An Asset to Health? 07/11/2021 Paul Adepoju & Elaine Ruth Fletcher GLASGOW – Nearly two dozen African countries, including some of the continent’s biggest methane- producing nations, have now signed The Global Methane Pledge, launched Tuesday at COP26 by United States President Joe Biden and the President of the European Commission, Ursula von der Leyen. While the pledge was initially announced in September with nine countries […] Continue reading -> Children’s Health Hit Hardest by Climate Change – but Cleaner Air, Greener Cities and Healthier Foods Can Create Cascade of Benefits 07/11/2021 Elaine Ruth Fletcher Greening cities, investing in urban bike lanes rather than new roads, and making plant-based foods cheaper and easier to access than ultra-processed foods. This is a doctor’s prescription for a healthier planet. As climate negotiators at Glasgow’s COP26 conference remain locked in debate over the big-picture ambition of targets for global CO2 emissions reductions, and […] Continue reading -> The African Medicines Agency Countdown 05/11/2021 Editorial team Thirty-nine of the African Union’s 55 member states have now signed and/or ratified the African Medicines Agency Treaty, as of 6 July 2024, with Kenya, the Democratic Republic of Congo and Cape Verde amongst the latest to swing behind the treaty. As the countdown for other nations to sign continues, Health Policy Watch is tracking […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Global COVID-19 Deaths: 5 Million and Counting 02/11/2021 Raisa Santos More than 5 million people have officially died from COVID-19 less than two years into the global pandemic. COVID-19 is now the third leading cause of death, after heart disease and stroke. There have been 5,003,021 COVID-19 related deaths as of 1 November, according to the Johns Hopkins COVID-19 Dashboard. In the United States, 746,021 […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Children’s Health Hit Hardest by Climate Change – but Cleaner Air, Greener Cities and Healthier Foods Can Create Cascade of Benefits 07/11/2021 Elaine Ruth Fletcher Greening cities, investing in urban bike lanes rather than new roads, and making plant-based foods cheaper and easier to access than ultra-processed foods. This is a doctor’s prescription for a healthier planet. As climate negotiators at Glasgow’s COP26 conference remain locked in debate over the big-picture ambition of targets for global CO2 emissions reductions, and […] Continue reading -> The African Medicines Agency Countdown 05/11/2021 Editorial team Thirty-nine of the African Union’s 55 member states have now signed and/or ratified the African Medicines Agency Treaty, as of 6 July 2024, with Kenya, the Democratic Republic of Congo and Cape Verde amongst the latest to swing behind the treaty. As the countdown for other nations to sign continues, Health Policy Watch is tracking […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Global COVID-19 Deaths: 5 Million and Counting 02/11/2021 Raisa Santos More than 5 million people have officially died from COVID-19 less than two years into the global pandemic. COVID-19 is now the third leading cause of death, after heart disease and stroke. There have been 5,003,021 COVID-19 related deaths as of 1 November, according to the Johns Hopkins COVID-19 Dashboard. In the United States, 746,021 […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The African Medicines Agency Countdown 05/11/2021 Editorial team Thirty-nine of the African Union’s 55 member states have now signed and/or ratified the African Medicines Agency Treaty, as of 6 July 2024, with Kenya, the Democratic Republic of Congo and Cape Verde amongst the latest to swing behind the treaty. As the countdown for other nations to sign continues, Health Policy Watch is tracking […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Global COVID-19 Deaths: 5 Million and Counting 02/11/2021 Raisa Santos More than 5 million people have officially died from COVID-19 less than two years into the global pandemic. COVID-19 is now the third leading cause of death, after heart disease and stroke. There have been 5,003,021 COVID-19 related deaths as of 1 November, according to the Johns Hopkins COVID-19 Dashboard. In the United States, 746,021 […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Global COVID-19 Deaths: 5 Million and Counting 02/11/2021 Raisa Santos More than 5 million people have officially died from COVID-19 less than two years into the global pandemic. COVID-19 is now the third leading cause of death, after heart disease and stroke. There have been 5,003,021 COVID-19 related deaths as of 1 November, according to the Johns Hopkins COVID-19 Dashboard. In the United States, 746,021 […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Global COVID-19 Deaths: 5 Million and Counting 02/11/2021 Raisa Santos More than 5 million people have officially died from COVID-19 less than two years into the global pandemic. COVID-19 is now the third leading cause of death, after heart disease and stroke. There have been 5,003,021 COVID-19 related deaths as of 1 November, according to the Johns Hopkins COVID-19 Dashboard. In the United States, 746,021 […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Global COVID-19 Deaths: 5 Million and Counting 02/11/2021 Raisa Santos More than 5 million people have officially died from COVID-19 less than two years into the global pandemic. COVID-19 is now the third leading cause of death, after heart disease and stroke. There have been 5,003,021 COVID-19 related deaths as of 1 November, according to the Johns Hopkins COVID-19 Dashboard. In the United States, 746,021 […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Global COVID-19 Deaths: 5 Million and Counting 02/11/2021 Raisa Santos More than 5 million people have officially died from COVID-19 less than two years into the global pandemic. COVID-19 is now the third leading cause of death, after heart disease and stroke. There have been 5,003,021 COVID-19 related deaths as of 1 November, according to the Johns Hopkins COVID-19 Dashboard. In the United States, 746,021 […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global COVID-19 Deaths: 5 Million and Counting 02/11/2021 Raisa Santos More than 5 million people have officially died from COVID-19 less than two years into the global pandemic. COVID-19 is now the third leading cause of death, after heart disease and stroke. There have been 5,003,021 COVID-19 related deaths as of 1 November, according to the Johns Hopkins COVID-19 Dashboard. In the United States, 746,021 […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> Posts navigation Older postsNewer posts